ClinicalTrials.Veeva

Menu

Low Dose Exposure to Oxidized R-limonene - A Repeated Open Application Test (ROAT) Study

H

Herlev and Gentofte Hospital

Status

Completed

Conditions

Allergic Contact Dermatitis Due to Cosmetics

Treatments

Other: ROAT with oxidized R-limonene at 1%, 0.3% and 0.1%
Other: ROAT with oxidized R-limonene at 1%

Study type

Interventional

Funder types

Other

Identifiers

NCT03313232
HGH-2017-017

Details and patient eligibility

About

This study evaluates the clinical and molecular effect of daily exposure to low doses of the fragrance contact allergen oxidized R-limonene. Three groups of participants are included: 1) Patients with a previous positive patch test to oxidized R-Limonene, 2) patients with a previous doubtful patch test to oxidized R-limonene and 3) healthy controls with no contact allergy to oxidized R-limonene

Enrollment

48 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Positive patch test (at least one reading) or doubtful patch test (at least two readings) to oxidized R-limonene 3% pet. (with 0.33% hydroperoxides content) according to international guidelines, within the last five years.
  • Aged 18 years or older
  • Received written and verbal information on the study.
  • Signed written consent form.

Exclusion criteria

  • Active eczema in test areas.
  • Pregnancy or breast feeding.
  • Treatment with topical corticosteroids or other immune-suppressants on/near test areas within two weeks prior to study start.
  • Systemic immune-suppressant treatment within seven days prior to study start.
  • UV exposure of test areas within three weeks prior to study start.
  • Unable to cooperate or communicate with the investigators.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

48 participants in 3 patient groups

Fragrance allergic patients
Experimental group
Description:
Patients with a previous positive patch test to oxidized R-Limonene. Patients will have an initial patch test dilution series with oxidized R-limonene performed on the back followed by twice daily exposure to oxidized R-limonene at three different concentrations and a vehicle control on the forearms for up to three weeks.
Treatment:
Other: ROAT with oxidized R-limonene at 1%, 0.3% and 0.1%
Possible fragrance allergic patients
Experimental group
Description:
Patients with a previous doubtful patch test to oxidized R-limonene. Patients will have an initial patch test dilution series with oxidized R-limonene performed on the back followed by twice daily exposure to oxidized R-limonene at three different concentrations and a vehicle control on the forearms for up to three weeks.
Treatment:
Other: ROAT with oxidized R-limonene at 1%, 0.3% and 0.1%
Healty controls
Experimental group
Description:
Healthy controls with no contact allergy to oxidized R-limonene. Healthy controls will have en initial diagnostic patch test with oxidized R-limonene performed followed by twice daily exposure to oxidized R-limonene at one concentration and a vehicle control on the forearms for up to three weeks.
Treatment:
Other: ROAT with oxidized R-limonene at 1%

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems